Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Robertson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Scientific Reports|September 18, 2020
Efficacy of microbicides for inactivation of Ebola-Makona virus on a non-porous surface: a targeted hygiene intervention for reducing virus spreadTodd A Cutts, Catherine Robertson, Steven S Theriault, et al.
Frontiers in Public Health|June 26, 2020
Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked WipesTodd A Cutts, Catherine Robertson, Steven S Theriault, et al.
Journal of Shoulder and Elbow Surgery|May 27, 2011
Full-thickness supraspinatus tears are associated with more synovial inflammation and tissue degeneration than partial-thickness tearsMichael K Shindle, Christopher C T Chen, Catherine Robertson, et al.
Scientific Reports|December 25, 2019
Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting diseaseJessy A Slota, Sarah J Medina, Megan Klassen, et al.
Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.
Blood|February 8, 2022
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALLSwati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Scientific Reports|September 18, 2020
Efficacy of microbicides for inactivation of Ebola-Makona virus on a non-porous surface: a targeted hygiene intervention for reducing virus spreadTodd A Cutts, Catherine Robertson, Steven S Theriault, et al.
Frontiers in Public Health|June 26, 2020
Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked WipesTodd A Cutts, Catherine Robertson, Steven S Theriault, et al.
Journal of Shoulder and Elbow Surgery|May 27, 2011
Full-thickness supraspinatus tears are associated with more synovial inflammation and tissue degeneration than partial-thickness tearsMichael K Shindle, Christopher C T Chen, Catherine Robertson, et al.
Scientific Reports|December 25, 2019
Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting diseaseJessy A Slota, Sarah J Medina, Megan Klassen, et al.
Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.
Blood|February 8, 2022
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALLSwati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Pageof 3